← Patent-cliff monitor small molecule TRYPTYR ACOLTREMON
Loss of exclusivity December 2042 latest FDA-listed patent expiry
Company Alcon → See this company's full patent-cliff portfolio Drug detail Brand name TRYPTYR Active ingredient ACOLTREMON Strength 0.003% Dosage form SOLUTION/DROPS Route OPHTHALMIC Modality Small molecule FDA approval May 2025 Marketing status RX
Listed patents Patent Expires Type 11850221 December 2042 product 12336971 December 2042 use U-1900 10028920 September 2031 use U-1900 9433679 September 2031 use U-1900 9095609 September 2031 product
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.